The University of Naples Federico II is a public university in Naples, Italy. Founded in 1224, it is the oldest public non-sectarian university in the world, and is now organized into 26 departments.

During the past decade, Federico II University Medical School conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Federico II University Medical School" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials, followed by "Gruppo Italiano Mammella (GIM)" with 3 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "European Institute of Oncology" with 2 trials sponsored and "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Federico II University Medical School" #1 collaborator was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Federico II University Medical School" are "Leukemia" (5 trials), "Lung Cancer" (4 trials), "Breast Cancer" (3 trials), "Bladder Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Federico II University Medical School" in a lesser frequency.

Most popular intervention types in "Federico II University Medical School" are "Drug" (16 trials), "Procedure" (8 trials), "Biological" (4 trials), "Radiation" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "etoposide" (6 trials), "cisplatin" (4 trials), "idarubicin" (4 trials), "mitoxantrone hydrochloride" (4 trials) and "radiation therapy" (4 trials). Other intervention names were less common.

The vast majority of trials in "Federico II University Medical School" are 15 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Federico II University Medical School". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Federico II University Medical School, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Federico II University Medical School, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".